zaragozic acid D (Merck)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namezaragozic acid D (Merck)
Drug Alias NameZaragozic acid D2zaragozic acid D2 (Merck)Zaragozic acid D
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSqualene synthase inhibitors
TargetsSqualene synthase
Therapy Area/IndicationsHypercholesterolemiaAtherosclerosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaAtherosclerosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A